A mouse model for human atherosclerosis:: Long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice

被引:78
作者
Coleman, Raymond
Hayek, Tony
Keidar, Shlomo
Aviram, Michael
机构
[1] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Anat & Cell Biol, IL-31096 Haifa, Israel
[2] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Lipid Res Lab, IL-31096 Haifa, Israel
[3] Technion Israel Inst Technol, Fac Med, Haifa, Israel
[4] Rambam Med Ctr, Haifa, Israel
关键词
review; histopathology; atherosclerosis; aortic arch; apolipoprotein; E-deficiency; mice;
D O I
10.1016/j.acthis.2006.07.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Apolipoprotein E-deficient mice, since their introduction in the early 1990s, have proved to be a very popular model for studying spontaneous hypercholesterolemia and the subsequent development of atherosclerotic lesions. The pathogenesis of atherosclerotic lesions in these mice mimics that found in humans on a very short time-scale. Atherosclerotic lesion development is especially prominent in the aortic arch. We have followed the progressive histopathological development of atherosclerotic lesions in the aortic arch of apolipoprotein E-deficient mice aged from 6 weeks to 18 months in 1 mu m epoxy-resin sections stained with alkaline toluidine blue, which gives greatly improved resolution over wax sections. During the early stages of lesion formation, lipid-filled macrophages appear in the subendothelium, and accumulate leading to "fatty streaks". Macrophage degeneration and the formation of lipid pools are accompanied by accumulation of cholesterol deposits. Disruptions of elastic laminae of the Tunica media are accompanied by structural changes in the myocytes. More advanced lesions involve fibrous cap development, calcification of the vessel wall and progressive occlusion of the lumen. Unstable plaque may also be found. Various approaches for quantitative determination of lesion size are considered. The study provides a histopathological baseline for spontaneous atherosclerosis associated with hypercholesterolemia, which can be used in connection with experimental interventional studies on the efficacy of drugs or foodstuffs in retardation of atherosclerosis. (C) 2006 Elsevier GmbH. All rights reserved.
引用
收藏
页码:415 / 424
页数:10
相关论文
共 21 条
[1]  
Aviram M, 2000, AM J CLIN NUTR, V71, P1062
[2]   The role of shear stress in the pathogenesis of atherosclerosis [J].
Cunningham, KS ;
Gotlieb, AI .
LABORATORY INVESTIGATION, 2005, 85 (01) :9-23
[3]   Apolipoprotein E and atherosclerosis: insight from animal and human studies [J].
Davignon, J ;
Cohn, JS ;
Mabile, L ;
Bernier, L .
CLINICA CHIMICA ACTA, 1999, 286 (1-2) :115-143
[4]  
Fuhrman B, 2000, J NUTR, V130, P1124
[5]   Grape powder polyphenols attenuate atherosclerosis development in apolipoprotein E deficient (EO) mice and reduce macrophage atherogenicity [J].
Fuhrman, B ;
Volkova, N ;
Coleman, R ;
Aviram, M .
JOURNAL OF NUTRITION, 2005, 135 (04) :722-728
[6]   Ramipril administration to atherosclerotic mice reduces oxidized low-density lipoprotein uptake by their macrophages and blocks the progression of atherosclerosis [J].
Hayek, T ;
Kaplan, M ;
Raz, A ;
Keidar, S ;
Coleman, R ;
Aviram, M .
ATHEROSCLEROSIS, 2002, 161 (01) :65-74
[7]   Omapatrilat decreased macrophage oxidative status and atherosclerosis progression in atherosclerotic apolipoprotein E-deficient mice [J].
Hayek, T ;
Hamoud, S ;
Keidar, S ;
Pavlotzky, E ;
Coleman, R ;
Aviram, M ;
Kaplan, M .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2004, 43 (01) :140-147
[8]   Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis [J].
Kaplan, M ;
Hayek, T ;
Raz, A ;
Coleman, R ;
Dornfeld, L ;
Vaya, J ;
Aviram, M .
JOURNAL OF NUTRITION, 2001, 131 (08) :2082-2089
[9]   Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development - A possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone [J].
Keidar, S ;
Kaplan, M ;
Pavlotzky, E ;
Coleman, R ;
Hayek, T ;
Hamoud, S ;
Aviram, M .
CIRCULATION, 2004, 109 (18) :2213-2220
[10]   Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient mice [J].
Keidar, S ;
Hayek, T ;
Kaplan, M ;
Pavlotzky, E ;
Hamoud, S ;
Coleman, R ;
Aviram, M .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2003, 41 (06) :955-963